Engineered NK Cells Against Cancer and Their Potential Applications Beyond

Area of Science:

• Immunology
• Oncology
• Cell Therapy

Background:

• Cell therapy, a 19th-century concept, has advanced medicine, particularly in oncology.
• Chimeric antigen receptor (CAR)-T cell therapy, a personalized immunotherapy, has achieved high response rates but faces challenges with toxicity and manufacturing.
• The merging of cell and gene therapy offers enhanced therapeutic options.

Purpose of the Study:

• To explore the potential of Natural Killer (NK) cells in CAR-based therapies.
• To discuss the applications of CAR-NK cells in cancer treatment.
• To highlight NK cells as a safer, off-the-shelf alternative to CAR-T cells.

Main Methods:

• Review of recent literature on CAR-NK cell therapy.
• Focus on the application of genetically modified cytotoxic lymphocytes.
• Discussion of NK cell properties, including antitumor potential and lifespan.

Main Results:

• CAR-T cell therapies demonstrate high objective response rates (up to 80%) in clinical trials.
• Life-threatening side effects and manufacturing complexities limit CAR-T cell therapy's widespread use.
• NK cells present potent antitumor properties and a shorter lifespan, suggesting a safer alternative.

Conclusions:

• CAR-NK cells represent a promising advancement in cancer immunotherapy.
• NK cells may offer a safer and more accessible 'off-the-shelf' therapeutic option.
• Further research into CAR-NK cell applications holds potential for broader cancer treatment strategies.